Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1806
TNBC
Basal A
Gefitinib
EGFR
ErbB
7830.016
uM
5.83110
20.84310
-0.2809 -1.0000 0.8625 0.2416
0.8887
2.0313
HCC1806
TNBC
Basal A
Gefitinib
EGFR
ErbB
9376.024
uM
5.89240
33.83110
-0.0465 -1.0000 0.6286 0.1926
0.9480
1.7329
HCC1806
TNBC
Basal A
Gefitinib
EGFR
ErbB
7829.016
uM
5.65810
56.83570
0.0749 -1.0000 0.4762 0.1818
0.9493
1.9532
HCC1806
TNBC
Basal A
Geldanamycin
HSP90
HSP90
9376.049
uM
0.45339
1.20540
-0.1143 -0.2675 0.4382 0.4463
0.8981
1.9229
HCC1806
TNBC
Basal A
Geldanamycin
HSP90
HSP90
7829.04
uM
0.08871
0.17866
-0.4305 -0.3385 0.7385 0.6451
0.9710
1.9437
HCC1806
TNBC
Basal A
Geldanamycin
HSP90
HSP90
9376.024
uM
0.09105
0.16670
-0.3874 -0.3398 0.8574 0.6465
0.9817
1.7329
HCC1806
TNBC
Basal A
Gemcitabine
DNA replication
DNA replication
9376.011
uM
0.0020
0.00271
-0.4566 -0.3593 1.7705 1.1418
0.9864
1.5809
HCC1806
TNBC
Basal A
Gemcitabine
DNA replication
DNA replication
7829.011
uM
0.00210
0.00301
-0.5201 -0.4810 1.8615 1.2324
0.9977
1.8746
HCC1806
TNBC
Basal A
Glycyl-H-1152
ROCK2
12239.16
uM
inf
8.170
0.6981 0.6893 1.6228 0.0296
0.9372
1.8654
HCC1806
TNBC
Basal A
GM6001
MMP
MMP
7451.096
uM
inf
1000.00000
0.7959 0.3531 0.2465 0.0736
0.8243
2.1851
HCC1806
TNBC
Basal A
GSK1070916
AURK
AURK
9376.001
uM
8.52810
15.2180
-0.6314 -1.0000 1.8970 0.1942
0.9775
1.8315
HCC1806
TNBC
Basal A
GSK1838705A
IGF1R
RTK
7451.091
uM
6.78910
7.13420
-0.7375 -0.1407 5.0000 0.3243
0.6889
2.1415
HCC1806
TNBC
Basal A
GSK1838705A
IGF1R
RTK
7450.071
uM
inf
0.74442
0.9009 0.8991 4.9999 0.0233
0.8174
2.3612
HCC1806
TNBC
Basal A
GSK1838705A
IGF1R
RTK
7450.098
uM
inf
6.96490
0.8269 0.8202 1.2453 0.0172
0.8654
2.2139
HCC1806
TNBC
Basal A
GSK1838705A
IGF1R
RTK
7450.091
uM
10.05510
12.42230
-0.9398 -0.9367 4.9924 0.3214
0.9962
1.0419
HCC1806
TNBC
Basal A
GSK461364
PLK1
PLK
9376.001
uM
0.01149
0.01275
-0.8414 -0.3412 5.0000 0.7692
0.90
1.8315
HCC1806
TNBC
Basal A
GSK923295
CENPE
Kinesin
9376.001
uM
0.04683
0.05049
-0.2653 -0.0881 2.1595 0.5459
0.9747
1.8315
HCC1806
TNBC
Basal A
GW-5074
CRAF
MAPK
7451.088
uM
inf
49.38090
0.8865 0.5406 2.8264 0.0196
0.6068
2.0920
HCC1806
TNBC
Basal A
Ibandronate
FDPS
12239.143
uM
38.4330
59.03320
-0.3065 -0.3557 1.2519 0.3960
0.9762
2.1267
HCC1806
TNBC
Basal A
ICRF-193
TOP2
TOP
12239.157
uM
inf
0.37078
0.6404 0.6618 0.8883 0.1335
0.9533
2.0946
HCC1806
TNBC
Basal A
IKK16
IKK
NFKB
7451.093
uM
1.01580
1.59470
-0.7628 -0.7676 2.0624 0.5440
0.9965
2.1935
HCC1806
TNBC
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
7450.091
uM
45.88880
56.78120
-0.9291 -0.9503 5.0000 0.5062
0.6984
1.0419
HCC1806
TNBC
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
7451.091
uM
7.19530
11.54340
-0.7850 -0.7228 1.8918 0.5267
0.9959
2.1415
HCC1806
TNBC
Basal A
Ispinesib
KSP
Kinesin
7451.067
uM
0.03055
0.03510
-0.7986 -0.2490 2.9143 0.6372
0.8808
2.0570
HCC1806
TNBC
Basal A
Ispinesib
KSP
Kinesin
7450.067
uM
0.02270
0.02744
-0.8269 -0.3126 2.5604 0.6793
0.9054
2.2419